(Q34557698)

3 August 2017

Prulifloxacin versus ciprofloxacin in the treatment of adults with complicated urinary tract infections (English)

1 reference

3 August 2017

Carmignani G

1

1 reference

3 August 2017

De Rose AF

2

1 reference

3 August 2017

Olivieri L

3

1 reference

3 August 2017

Salvatori E

4

1 reference

3 August 2017

Rosignoli MT

5

1 reference

3 August 2017

Dionisio P

6

1 reference

3 August 2017

1 January 2005

1 reference

3 August 2017

Urologia Internationalis

1 reference

3 August 2017

74

1 reference

3 August 2017

4

1 reference

3 August 2017

326-331

1 reference

Extended-release ciprofloxacin (Cipro XR) for treatment of urinary tract infections

3 August 2017

1 reference

Which fluoroquinolones are suitable for the treatment of urinary tract infections?

21 January 2018

1 reference

In vitro antibacterial activities of AF 3013, the active metabolite of prulifloxacin, against nosocomial and community Italian isolates.

21 January 2018

1 reference

Trials to assess equivalence: the importance of rigorous methods

21 January 2018

1 reference

A randomized, double-blind, multicenter comparison of gatifloxacin versus ciprofloxacin in the treatment of complicated urinary tract infection and pyelonephritis

21 January 2018

1 reference

Efficacy of ertapenem in the treatment of serious infections caused by Enterobacteriaceae: analysis of pooled clinical trial data

21 January 2018

1 reference

Urinary tract infections: what's new?

21 January 2018

1 reference

In Vitro Activity of the Active Metabolite of Prulifloxacin (AF 3013) Compared with Six Other Fluoroquinolones

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000084432

1 reference

3 August 2017

1 reference